Caroline Baumal - Jan 17, 2025 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief Medical Officer
Signature
/s/ David Watson, attorney-in-fact for Caroline Baumal
Stock symbol
APLS
Transactions as of
Jan 17, 2025
Transactions value $
-$55,513
Form type
4
Date filed
1/21/2025, 03:54 PM
Previous filing
Jan 8, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale -$55.5K -1.85K -3.34% $29.96 53.7K Jan 17, 2025 Direct F1
transaction APLS Common Stock Award $0 +39.6K +73.72% $0.00 93.3K Jan 21, 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 16, 2025.
F2 This represents a Restricted Stock Unit award granted on January 21, 2025 that vest 25% annually over four years from grant date subject to continued service.